Core Viewpoint - The announcement details the judicial auction of 200 million shares held by the controlling shareholder, Shanghai Zhongneng, which constitutes 29.20% of the total share capital of Ningxia Zhongke Biotechnology Co., Ltd. This event may lead to significant changes in the company's ownership structure and governance [1][4]. Summary by Sections 1. Basic Situation of Judicial Auction - The judicial auction is scheduled to take place from September 29, 2025, to September 30, 2025, on the JD Network Judicial Auction Platform [2]. - The shares being auctioned are 200 million unrestricted circulating shares [2]. 2. Progress of Judicial Auction - Shanghai Zhongneng confirmed that there are no unfulfilled commitments related to the shares being auctioned [3]. - The shares are pledged to Guangzhou Rural Commercial Bank, and the auction proceeds will be used to repay a loan of approximately 1.11 billion yuan [3][4]. 3. Relevant Litigation and Rulings - The court has issued a ruling for the auction of 200 million shares held by Shanghai Zhongneng due to a loan default [4]. - The ruling is effective immediately upon delivery [4]. 4. Other Information - The auction is still in the public notice phase, and the outcome remains uncertain, which could significantly impact the company's operational and governance structure if the auction is successful [4][5].
ST宁科: ST宁科关于控股股东股份将被司法拍卖的进展公告